worldwide offices | contact | help | sitemap

 

 

 

 

Business development & licensing

Business development & licensing

Our areas of interest

We are interested in identifying and evaluating vaccine products and technologies to:

  • Enhance our existing franchises
  • Build our vaccine pipeline
  • Expand our marketed portfolio
  • Establish greater geographic presence
  • Strengthen our research and development activities

We are actively pursuing partnering opportunities in the following area:

  • Vaccine products and candidates
  • Delivery systems, adjuvants, and immune-modulators
  • Needle-free devices for vaccine delivery
  • Technology to improve vaccine formulation, presentation, convenience, stability and reduce cold-chain requirements
  • Tools and technologies for vaccine development such as antigen screening, manufacturing process scale-up, in-vitro system to predict human immunity, specific cell targeting strategies to enhance vaccine delivery

We welcome and invite interested external parties to submit their opportunity proposal or inquiry to: bdlopportunity.nvd@novartis.com

 

Disease & products

disease & products

Learn about meningitis, influenza, rabies, TBE and japanese encephalities.

Newsroom

Newsroom

Discover up-to-date Novartis Vaccines information.